Paul J. Mellett
2016
In 2016, Paul J. Mellett earned a total compensation of $1.2M as Senior Vice President, Finance & Administration and Chief Financial Officer at Enanta Pharmaceuticals, a 20% decrease compared to previous year.
Compensation breakdown
Bonus | $93,893 |
---|---|
Non-Equity Incentive Plan | $43,503 |
Option Awards | $595,278 |
Salary | $359,930 |
Stock Awards | $108,301 |
Other | $15,857 |
Total | $1,216,762 |
Mellett received $595.3K in option awards, accounting for 49% of the total pay in 2016.
Mellett also received $93.9K in bonus, $43.5K in non-equity incentive plan, $359.9K in salary, $108.3K in stock awards and $15.9K in other compensation.
Rankings
In 2016, Paul J. Mellett's compensation ranked 7,308th out of 14,075 executives tracked by ExecPay. In other words, Mellett earned more than 48.1% of executives.
Classification | Ranking | Percentile |
---|---|---|
All | 7,308 | 48th |
Manufacturing | 2,758 | 50th |
Chemicals And Allied Products | 902 | 53rd |
Drugs | 701 | 55th |
Pharmaceutical Preparations | 557 | 53rd |
Mellett's colleagues
We found four more compensation records of executives who worked with Paul J. Mellett at Enanta Pharmaceuticals in 2016.
News
Enanta Pharmaceuticals CEO Jay Luly's 2022 pay jumps 37% to $7.3M
January 20, 2023
Enanta Pharmaceuticals CEO Jay Luly's 2021 pay rises 2% to $5.3M
January 21, 2022
Enanta Pharmaceuticals CEO Jay Luly's 2020 pay rises 16% to $5.2M
January 21, 2021
Enanta Pharmaceuticals CEO Jay Luly's 2019 pay slips 1% to $4.5M
January 17, 2020
Enanta Pharmaceuticals CEO Jay Luly's 2018 pay rises 5% to $4.5M
January 18, 2019